A load of crap from an idle brain

The good news is that scientific research papers being filed from India are on the upswing.  The bad news is that countries like China, Korea etc have left India long behind in this race.  In fact, China has more than doubled its research output since 2004.  Read more on these reports at this Thomson Reuters website.

Often referred to as a “sleeping giant” in scientific literature, India seems to be waking out of its slumber, says a recent global research report on “Research and Collaboration in the new Geography of Science” by Thomson Reuters.

As per the report, Chemistry and Pharmacology are fast becoming the most “published” disciplines in India; USA remains its largest research partner even as South Korea is racing ahead of China to partner with India. And Japan’s University of Tokyo collaborates most frequently with Indian researchers.

If the current trajectory continues, the study estimates, India’s productivity would well be on par with that of most G-8 nations within eight years and could even overtake them between 2015-2020.

In a testament to its strength in information technology, computer science accounted for the highest increase in world publications from India between 1999-2003 and 2004-2008, increasing by more than 100%. When it comes to research, India’s strength lies in Chemistry and emerging sectors like pharmacology, microbiology and traditional agricultural sciences.

Between 1993-2003 and 2004-08:

• In Chemistry, India’s research output increased from 21,206 world publications to 33,504

• From a 2.8 per cent share of the world output in pharmacology and toxicology, India’s share is up to 4.25 per cent

• Output in engineering rose from 2.69 per cent to 3.57 per cent

• Microbiology saw publication output rise from 1.62 per cent to 2.79 per cent

Agricultural engineering, Tropical Medicine, Organic Chemistry and Dairy & Animal Science are areas of research where India is picking up well besides Crystallography and Textiles.

Read the full news here

Above picture source: 30yearchallenge

+++

India’s top biotechnology firm, Biocon Ltd, has agreed to buy 70 percent of German marketing firm AxiCorp GmbH for 30 million euros ($43.7 million) to boost its business in overseas markets, Biocon said on Monday.

The acquisition will enable marketing and distribution of a range of pharmaceuticals including generics, biosimilars, biologics and other products in Germany and other European countries, the Indian drugmaker said.

Full article here.

+++

More about the event (February 7 to 9th) at the Bio Asia 2008 website.

+++